miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 11, 2026

‘I had hoped to be retired’: 66-year-old still works 11-hour days with zero savings. Here’s how you can avoid this fate

View original at finance.yahoo.com
‘I had hoped to be retired’: 66-year-old still works 11-hour days with zero savings. Here’s how you can avoid this fate Photo: CBS News Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Financial situation has been life-threatening

    80% confidence
  • Approximately one in five Americans aged 65 and over were employed in 2023

    80% confidence
  • Moby's stock recommendations have beaten the S&P 500 by almost 12% on average over four years across almost 400 stock picks

    80% confidence
  • Nearly half of U.S. women aged 55 to 66 have no personal retirement savings

    80% confidence
  • She works 11-hour days across two jobs with no savings, 401(k), or emergency fund

    80% confidence
  • Only 43% of American adults could handle an unexpected $1,000 expense with their savings

    80% confidence
  • She had hoped to be retired, playing piano and enjoying life

    80% confidence
  • 47% of men aged 55 to 66 have no personal retirement savings

    80% confidence
  • Gold could climb to $6,200 per ounce by the end of 2026

    80% confidence
  • Employment rate for Americans 65+ has nearly doubled compared to 35 years ago

    80% confidence
  • Recommends saving enough to cover three to six months of living expenses for emergencies

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com